期刊文献+

COL1A1突变导致成骨不全症1例

原文传递
导出
摘要 成骨不全症又称脆骨病,是一种单基因突变导致胶原生成功能障碍的罕见骨疾病,主要特点是成骨量下降、骨质脆性增加、反复骨折、蓝巩膜、牙本质发育异常以及听力异常^([1])。90%以上的成骨不全症是由Ⅰ型胶原蛋白编码基因COL1A1或COL1A2突变引起的,遗传性模型大多呈常染色体显性遗传,少部分呈常染色体隐性遗传,甚至罕见X染色体伴性遗传^([2])。
出处 《中国骨与关节损伤杂志》 2023年第6期663-664,共2页 Chinese Journal of Bone and Joint Injury
  • 相关文献

参考文献4

二级参考文献83

  • 1CundyT.Recentadvancesinosteogenesisimperfecta[J].CalcifTissueInt,2012,90:439449.
  • 2vanDijkFS,CobbenJM,KariminejadA,MaugeriA,NikkelsPG,vanRijnRR,etal.Osteogenesisimperfecta:areviewwithclinicalexamples[J].MolSyndromol,2011,2:120.
  • 3SillenceDO,SennA,DanksDM.Geneticheterogeneityinosteogenesisimperfecta[J].JMedGenet,1979,16:101116.
  • 4vanDijkFS,Pals G,van Rijn R R,Nikkels P G,CobbenJ M.Classificationofosteogenesisimperfectarevisited[J].EurJMedGenet,2010,53:15.
  • 5RussellRG.Bisphosphonates:modeofactionandpharmacology[J].Pediatrics,2007,119(Suppl2):S150S162.
  • 6GlorieuxFH,BishopNJ,PlotkinH,ChabotG,LanoueG,TraversR.Cyclicadministrationofpamidronateinchildrenwithsevereosteogenesisimperfecta[J].NEnglJMed,1998,339:947952.
  • 7GlorieaxFH,BishopN,BoberM,BrainCE,DevougelareJFeketeG,etal.Lowdose,singledaypamidronattreatmentinosteogenesisimperfecta[J].Horm ResPaediatr,2011,76:153.
  • 8Gk爧enD,CokerM,DarcanS,KseT,KaraS.Lowdoseintravenouspamidronatetreatmentinosteogenesisimperfecta[J].TurkJPediatr,2006,48:124129.
  • 9OliveiraTP,AndradeM C,PetersBSE,ReisFA,CarvalhaesJTA,LazarettiCastroM.Renalsafetyof2hourpamidronateinfusionforosteogenesisimperfectapatients[J].ArchOsteoporos,2012,7:S199.
  • 10BishopN,HarrisonR,AhmedF,Shaw N,EastellR,CampbellM,etal.Arandomized,controlleddoserangingstudyofrisedronateinchildrenwithmoderateandsevereosteogenesisimperfecta[J].JBoneMinerRes,2010,25:3240.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部